Search Results
Emma Ahlqvist
Emma Ahlqvist
Department of Clinical Sciences, Malmö , Lund University, Malmö, Sweden
Search for other papers by Emma Ahlqvist in
Google Scholar
PubMed
Search for other papers by Emma Ahlqvist in
Google Scholar
PubMed
Rashmi B Prasad
Rashmi B Prasad
Department of Clinical Sciences, Malmö , Lund University, Malmö, Sweden
Institute for Molecular Medicine Finland (FIMM), Helsinki University, Helsinki, Finland
Search for other papers by Rashmi B Prasad in
Google Scholar
PubMed
Institute for Molecular Medicine Finland (FIMM), Helsinki University, Helsinki, Finland
Search for other papers by Rashmi B Prasad in
Google Scholar
PubMed
Leif Groop
Leif Groop
Department of Clinical Sciences, Malmö , Lund University, Malmö, Sweden
Institute for Molecular Medicine Finland (FIMM), Helsinki University, Helsinki, Finland
Search for other papers by Leif Groop in
Google Scholar
PubMed
Institute for Molecular Medicine Finland (FIMM), Helsinki University, Helsinki, Finland
Search for other papers by Leif Groop in
Google Scholar
PubMed
had the lowest estimated glomerular filtration rate (eGFR) already at diabetes diagnosis and were thus already at increased risk of developing chronic kidney disease (CKD), macroalbuminuria and end-stage renal disease (ESRD). In the SDR cohort, SIRD
Jennifer M Ikle
Jennifer M Ikle
Division of Endocrinology, Department of Pediatrics, Stanford University School of Medicine, Stanford, California, USA
Search for other papers by Jennifer M Ikle in
Google Scholar
PubMed
Search for other papers by Jennifer M Ikle in
Google Scholar
PubMed
Anna L Gloyn
Anna L Gloyn
Division of Endocrinology, Department of Pediatrics, Stanford University School of Medicine, Stanford, California, USA
Stanford Diabetes Research Center, Stanford University, Stanford, California, USA
Search for other papers by Anna L Gloyn in
Google Scholar
PubMed
Stanford Diabetes Research Center, Stanford University, Stanford, California, USA
Search for other papers by Anna L Gloyn in
Google Scholar
PubMed
sodium-glucose transporter in the kidney ( SGLT2 ), therefore, patients with HNF1A-MODY have a low renal threshold for glucose ( Pontoglio et al. 2000 ). Functional studies have demonstrated that protein-truncating mutations result in
Jennifer Chen
Jennifer Chen
The Westmead Institute for Medical Research, The University of Sydney Westmead Hospital, New South Wales, Australia
Search for other papers by Jennifer Chen in
Google Scholar
PubMed
Search for other papers by Jennifer Chen in
Google Scholar
PubMed
Jenny E Gunton
Jenny E Gunton
The Westmead Institute for Medical Research, The University of Sydney Westmead Hospital, New South Wales, Australia
Department of Endocrinology and Diabetes, Westmead Hospital, Sydney, New South Wales, Australia
Garvan Institute of Medical Research, Sydney, New South Wales, Australia
St Vincent’s Clinical School, University of New South Wales, Sydney, New South Wales, Australia
Search for other papers by Jenny E Gunton in
Google Scholar
PubMed
Department of Endocrinology and Diabetes, Westmead Hospital, Sydney, New South Wales, Australia
Garvan Institute of Medical Research, Sydney, New South Wales, Australia
St Vincent’s Clinical School, University of New South Wales, Sydney, New South Wales, Australia
Search for other papers by Jenny E Gunton in
Google Scholar
PubMed
damage to the kidney in people with diabetes. Moreover, some of the immunosuppressive medications used in islet transplant recipients can cause renal impairment. The current clinical site for human islet grafts, the portal vein, leads to marked loss of
